Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.

Pawankumar Suresh enhances early-stage drug research processes, ensuring regulatory compliance through effective systems and vendor governance.

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Pfizer scrapped its own obesity drug candidate, Danuglipron, in early 2025, citing risks of liver enzyme elevations. ・The ...

A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

Altasciences, a fully integrated drug development solution company, and VoxCell BioInnovation (“VoxCell”), a leader in 3D bioprinting and human-like tissue modeling, are pleased to announce a ...

A new AI breakthrough could slash the time it takes to discover life-saving medicines, according to researchers in ...

This episode of the Pharmaron DMPK Insights Podcast Series sees Simon Taylor (Vice President of Drug Discovery at Pharmaron) and Dr. Emile Chen (former Director of Modeling and Translational Biology ...